Traditional Drug Discovery

Traditional drug discovery is a sequential, hypothesis-driven process for identifying and developing new therapeutic compounds, typically involving target identification, lead compound screening, optimization, and preclinical testing. It relies heavily on experimental techniques like high-throughput screening, medicinal chemistry, and animal models to evaluate efficacy and safety. This approach has been the foundation of pharmaceutical development for decades, leading to many approved drugs.

Also known as: Classical Drug Discovery, Conventional Drug Discovery, Empirical Drug Discovery, HTS-based Discovery, Small Molecule Discovery

Why learn Traditional Drug Discovery?

Developers should learn about traditional drug discovery when working in bioinformatics, computational biology, or pharmaceutical software to understand the historical context and constraints of drug development pipelines. It's essential for building tools that support target validation, compound screening data analysis, or regulatory compliance in legacy systems. Knowledge of this methodology helps in integrating computational approaches with experimental workflows in drug R&D.

Learning Resources

• book: Drug Discovery: A History
• course: Introduction to Drug Discovery
• docs: Traditional vs. Modern Drug Discovery Methods
• video: High-Throughput Screening in Drug Discovery
• tutorial: Medicinal Chemistry: Principles and Practice